{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:43:38Z","timestamp":1790765018989,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T00:00:00Z","timestamp":1544918400000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DESC0008432"],"award-info":[{"award-number":["DESC0008432"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DESC0012737"],"award-info":[{"award-number":["DESC0012737"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH092797"],"award-info":[{"award-number":["MH092797"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NS103957"],"award-info":[{"award-number":["NS103957"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NS075527"],"award-info":[{"award-number":["NS075527"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NS103988"],"award-info":[{"award-number":["NS103988"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejphar.2017.12.006","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T10:59:57Z","timestamp":1512644397000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease"],"prefix":"10.1016","volume":"820","author":[{"given":"Hongjun","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Resing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyi","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrance M.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.12.006_bib1","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1016\/j.bmcl.2010.07.033","article-title":"Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor","volume":"20","author":"Abdi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.12.006_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1476-5381.2010.01025.x","article-title":"Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat","volume":"162","author":"Able","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","article-title":"The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease","volume":"66","author":"Bartlett","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2017.12.006_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2008.10.018","article-title":"Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders","volume":"198","author":"Basso","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2017.12.006_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/glia.23001","article-title":"The microglial ATP-gated ion channel P2X7 as a CNS drug target","volume":"64","author":"Bhattacharya","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2017.12.006_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1471-4159.2006.04101.x","article-title":"A role for P2X7 in microglial proliferation","volume":"99","author":"Bianco","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2017.12.006_bib8","doi-asserted-by":"crossref","first-page":"13446","DOI":"10.1074\/jbc.M901255200","article-title":"Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cells","volume":"284","author":"Boumechache","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.12.006_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1113\/expphysiol.2008.043620","article-title":"Purinergic cotransmission","volume":"94","author":"Burnstock","year":"2009","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0100-879X2008005000037","article-title":"Purinergic signalling: past, present and future","volume":"42","author":"Burnstock","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejphar.2017.12.006_bib11","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.bmcl.2010.03.096","article-title":"Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor","volume":"20","author":"Chambers","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.12.006_bib12","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.bjp.0701278","article-title":"Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells","volume":"121","author":"Chessell","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0028-3908(97)00140-8","article-title":"Tissue distribution of the P2X7 receptor","volume":"36","author":"Collo","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2017.12.006_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2008.06.012","article-title":"[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors","volume":"56","author":"Donnelly-Roberts","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2017.12.006_bib16","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-08894-5_11","article-title":"Pathological potential of astroglial purinergic receptors","volume":"11","author":"Franke","year":"2014","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.bmcl.2015.03.021","article-title":"Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor","volume":"25","author":"Gao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.12.006_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2016.02.003","article-title":"Early P2X7R-related astrogliosis in autoimmune encephalomyelitis","volume":"74","author":"Grygorowicz","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2017.12.006_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MNM.0000000000000660","article-title":"Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response","volume":"38","author":"Han","year":"2017","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ejphar.2017.12.006_bib21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1124\/jpet.106.111559","article-title":"A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat","volume":"319","author":"Honore","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.12.006_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jlcr.3206","article-title":"Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [(1)(1)C]A-740003 as a novel tracer of neuroinflammation","volume":"57","author":"Janssen","year":"2014","journal-title":"J. Label. Comp. Radiopharm."},{"key":"10.1016\/j.ejphar.2017.12.006_bib23","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy","volume":"36","author":"Jimenez-Pacheco","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2017.12.006_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/ml400040v","article-title":"Synthesis and pharmacological characterization of two novel, brain penetrating P2X7 antagonists","volume":"4","author":"Letavic","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.12.006_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/NEN.0000000000000241","article-title":"Neuroinflammatory gene regulation, mitochondrial function, oxidative stress, and brain lipid modifications with disease progression in Tau P301S transgenic mice as a model of frontotemporal lobar degeneration-Tau","volume":"74","author":"Lopez-Gonzalez","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejphar.2015.09.026","article-title":"A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334","volume":"765","author":"Lord","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2006.01.009","article-title":"Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors","volume":"534","author":"Michel","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib28","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1523\/JNEUROSCI.5512-08.2009","article-title":"The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore","volume":"29","author":"Monif","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2017.12.006_bib29","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.biocel.2010.06.021","article-title":"Microglia: proliferation and activation driven by the P2X7 receptor","volume":"42","author":"Monif","year":"2010","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.ejphar.2017.12.006_bib30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2967\/jnumed.115.169995","article-title":"Preclinical evaluation of a P2X7 receptor-selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in nonhuman primates","volume":"57","author":"Ory","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2017.12.006_bib31","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1021\/acs.jmedchem.5b01690","article-title":"Potent suppressive effects of 1-piperidinylimidazole based novel P2X7 receptor antagonists on cancer cell migration and invasion","volume":"59","author":"Park","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.12.006_bib32","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.12.006_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2967\/jnumed.116.181354","article-title":"Characterization of [11C]-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation","volume":"58","author":"Territo","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2017.12.006_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917307926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917307926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:40:20Z","timestamp":1787946020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917307926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"alternative-id":["S0014299917307926"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.12.006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}